Connection

Stephen Kent to Antibody Formation

This is a "connection" page, showing publications Stephen Kent has written about Antibody Formation.
Connection Strength

0.651
  1. Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19. Nat Commun. 2021 02 19; 12(1):1162.
    View in: PubMed
    Score: 0.333
  2. Systems serology detects functionally distinct coronavirus antibody features in children and elderly. Nat Commun. 2021 04 01; 12(1):2037.
    View in: PubMed
    Score: 0.084
  3. Integrated immune dynamics define correlates of COVID-19 severity and antibody responses. Cell Rep Med. 2021 03 16; 2(3):100208.
    View in: PubMed
    Score: 0.083
  4. Partial efficacy of a broadly neutralizing antibody against cell-associated SHIV infection. Sci Transl Med. 2017 Aug 09; 9(402).
    View in: PubMed
    Score: 0.065
  5. Dimeric Fc? Receptor Enzyme-Linked Immunosorbent Assay To Study HIV-Specific Antibodies: A New Look into Breadth of Fc? Receptor Antibodies Induced by the RV144 Vaccine Trial. J Immunol. 2017 07 15; 199(2):816-826.
    View in: PubMed
    Score: 0.065
  6. Immunogenicity of prime-boost protein subunit vaccine strategies against SARS-CoV-2 in mice and macaques. Nat Commun. 2021 03 03; 12(1):1403.
    View in: PubMed
    Score: 0.021
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.